SCHEMBL9674654

SCHEMBL9674654

O=C(O)NNC(=O)c1cccc(O)c1O

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TERT O14746 2/20 0.56
ALOX5 P09917 1/20 0.56
NPC1 O15118 5/20 0.49
RAB9A P51151 4/20 0.49
CA1 P00915 4/20 0.49
CA9 Q16790 4/20 0.49
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L1CAM P32004 1/20 0.46
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
RECQL P46063 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4229962 0.92 TERT (0.63) TERTALOX5NPC1RAB9ACA1
SCHEMBL4218154 0.86 CA1 (0.65) TERTALOX5NPC1RAB9ACA1
SCHEMBL1436240 0.78 GAA (0.69) TERTALOX5NPC1CA1ALDH1A1
SCHEMBL32018464 0.78 TERT (0.61) TERTALOX5CA1CA9ALDH1A1
SCHEMBL723254 0.78 TERT (0.61) TERTALOX5CA1CA9ALDH1A1
SCHEMBL4230145 0.78 KMT2A (0.63) TERTNPC1RAB9AALDH1A1KDM4E
SCHEMBL4235075 0.78 LMNA (0.61) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL4223765 0.76 TLR7 (0.60) TERTALOX5NPC1RAB9ACA1
SCHEMBL23117963 0.76 ALOX5 (0.59) TERTALOX5NPC1CA1CA9
SCHEMBL8983169 0.76 ALOX5 (0.59) TERTALOX5NPC1CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0251143-B1 2-Oxo-1-[[(Substituted Sulfonyl)Amino]-Carbonyl]Azetidines Bristol-Myers Squibb GmbH (DE) 1992-08-26 EP disclosed
US-4801705-A 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines E. R. SQUIBB & SONS, INC. (US) 1989-01-31 US disclosed
EP-0251143-A1 2-Oxo-1-[[(Substituted Sulfonyl)Amino]-Carbonyl]Azetidines Bristol-Myers Squibb GmbH (DE) 1988-01-07 EP disclosed